Skip to main content
Antimicrobial Resistance and Infection Control logoLink to Antimicrobial Resistance and Infection Control
. 2022 Nov 23;11:144. doi: 10.1186/s13756-022-01184-x

Effect of temperature on Escherichia coli bloodstream infection in a nationwide population-based study of incidence and resistance

Sarah F Feldman 1, Elizabeth Temkin 1, Liat Wulffhart 1, Amir Nutman 1,2, Vered Schechner 1,2, Pnina Shitrit 2,3, Racheli Shvartz 1, Mitchell J Schwaber 1,2, Yehuda Carmeli 1,2,✉
PMCID: PMC9685946  PMID: 36424647

Abstract

Background

The incidence of Escherichia coli bloodstream infections (BSI) is high and increasing. We aimed to describe the effect of season and temperature on the incidence of E. coli BSI and antibiotic-resistant E. coli BSI and to determine differences by place of BSI onset.

Methods

All E. coli BSI in adult Israeli residents between January 1, 2018 and December 19, 2019 were included. We used the national database of mandatory BSI reports and outdoor temperature data. Monthly incidence and resistance were studied using multivariable negative binomial regressions with season (July–October vs. other) and temperature as covariates.

Results

We included 10,583 events, 9012 (85%) community onset (CO) and 1571 (15%) hospital onset (HO). For CO events, for each average monthly temperature increase of 5.5 °C, the monthly number of events increased by 6.2% (95% CI 1.6–11.1%, p = 0.008) and the monthly number of multidrug-resistant events increased by 4.9% (95% CI 0.3–9.7%, p = 0.04). The effect of season was not significant. For HO events, incidence of BSI and resistant BSI were not associated with temperature or season.

Conclusion

Temperature increases the incidence of CO E. coli BSI and CO antibiotic-resistant E. coli BSI. Global warming threatens to increase the incidence of E. coli BSI.

Supplementary Information

The online version contains supplementary material available at 10.1186/s13756-022-01184-x.

Keywords: Escherichia coli, Bloodstream infection, Antibiotic resistance, Epidemiology, Temperature, Seasonal variation

Introduction

The impact of Escherichia coli bloodstream infection (BSI) is high in terms of incidence, antibiotic resistance, and mortality [1, 2]. A global increase in the incidence of E. coli BSI has been described [3, 4], with seasonal variations: the incidence rises with the warm season [5–10] and with increased temperature [4, 6, 8, 10]. Explanations for the seasonality of the incidence of E. coli BSI include higher E. coli colonization in humans during the summer because of behavior changes and modification of host immunity [10, 11], and increased virulence and growth of E. coli in food and in the environment [6, 10–12].

Several aspects of seasonality in E. coli BSI require further assessment. It is unclear whether seasonality in the incidence of E. coli BSI differs between community-onset (CO) events and hospital-onset (HO) events [7–9]. It is unknown if seasonality affects resistance. To our knowledge, only one study was conducted, in Oxfordshire, England in 1999–2011, and found a non-significant increase in the incidence of resistant events at higher temperatures [4].

The aim of the present study was to describe the effect of season and outdoor temperature on the incidence of E. coli BSI and antibiotic-resistant E. coli BSI, by place of onset.

Methods

Data sources

All acute care hospitals in Israel send mandatory monthly reports of BSI caused by sentinel pathogens, including E. coli, to the National Institute for Antibiotic Resistance and Infection Control, as described previously [2]. Those reports include the patient’s name, date of birth, national identity number, age, sex, admission date, ward, sample date, pathogens isolated, and results of antibiotic susceptibility testing. Data were de-identified for the purposes of this study. We used publicly available outdoor temperature data from the Ministry of Transportation [13]. We calculated the monthly mean of daily maximum outdoor temperature using data from January 1, 2018, to December 31, 2019 from four stations in Israel (Haifa, Tel Aviv, Jerusalem, and Mitzpe Ramon).

Study sample

All E. coli BSI that occurred between January 1, 2018 and December 31, 2019 in patients aged 18 and over were included in the analysis. We excluded events with a missing or implausible admission date and thus an undefined place of onset.

Definitions

An E. coli BSI event was defined as a blood culture positive for E. coli. The date of onset of the event was the date of blood sample collection. If a blood culture was positive for another sentinel pathogen (Acinetobacter baumannii, Enterococcus faecalis, Enterococcus faecium, Klebsiella pneumoniae, Pseudomonas aeruginosa, Staphylococcus aureus, or Streptococcus pneumoniae) within 5 days before or after an E. coli BSI event, the event was defined as polymicrobial. An event was defined as CO if it occurred within the first 3 days of hospital admission, and as HO otherwise. We defined seasons as winter (December–February), spring (March–May), summer (June–August), and autumn (September–November). We also modelled season dichotomously as holiday season (July–October), which corresponds in Israel to both a hot period and a period when many people are on vacation, vs. the rest of the year. E. coli was classified according to the hospitals’ laboratory reports as susceptible, intermediate or resistant to a given antibiotic. We grouped together isolates that were intermediate or resistant. Multidrug resistance (MDR) was defined as resistance to three or more antimicrobial classes [14].

Statistical analysis

No sample size calculations were performed for this population-based study; we included all cases of BSI in adults during the study period. Variables were described by mean and standard deviation (SD) or by count and percentage, as appropriate. The mean number of events per month was compared between seasons using negative binomial regression. Age was compared between seasons using Student’s t-test or ANOVA. Categorical variables were compared between seasons using the chi-square test of independence.

Seasonal variation was assessed by fitting a sinusoidal curve to the total monthly number of events and computing the peak-to-low ratio (i.e., the ratio of the peak monthly number of events to the lowest monthly number of events on the sinusoidal curve) and its 95% confidence interval (CI). The peak-to-low ratio was calculated using moment-based estimation, with non-transformed data and a second-order moment statistic, as previously described [15].

The monthly number of events was standardized and plotted by temperature. The monthly number of CO events was plotted by temperature and by age category. A simple linear model of the monthly number of CO events by temperature was computed in each age category and the coefficient of temperature was plotted. The monthly number of events by temperature was plotted by MDR status and was fitted using a third degree polynomial. The monthly number of events and the monthly number of resistant events were modeled using negative binomial regression. CO and HO events were studied separately in all models. The explanatory variables were season (holiday season vs. rest of the year), temperature, sex, age category and the number of months since January 2018 to account for an increasing trend in incidence. Incidence rate ratio (IRR), 95% CI and p values were calculated. Variables were selected based on knowledge and availability, without a statistical selection process.

The monthly peak-to-low ratio, its 95% CI and the time of peak were computed using Episheet (https://www.drugepi.org/dope/software#Episheet). All other analysis were performed using R version 4.0.4.

Results

Effect of season on incidence

We analyzed 10,583 E. coli BSI events in 9733 patients, after exclusion of 530 events with an unknown place of onset. A total of 9012 (85.2%) events were CO and 1571 (14.8%) were HO. The mean age was lower during the holiday season for CO events (72.6 [SD 17.0] in the holiday season vs. 73.9 [SD 16.4] during the rest of the year; p < 0.001) but was similar in the two periods for HO events (p = 0.6) (Table 1).

Table 1.

Characteristics of E. coli bloodstream infections by place of onset and by season

Variable Community onset Hospital onset
(n = 9012) (n = 1571)
Holiday season Rest of the year P Holiday season Rest of the year P
E. coli BSI per month, mean (SD) 410.5 (29.6) 357.9 (35.3)  < 0.001 69 (8.8) 63.7 (7.7) 0.13
Age, mean (SD) 72.6 (17.0) 73.9 (16.4)  < 0.001 67.1 (17.0) 67.6 (17.1) 0.56
Age category, N (%)  < 0.001 0.73
 18–44 268 (8.2) 396 (6.9) 66 (12.0) 120 (11.8)
 45–64 527 (16.0) 870 (15.2) 130 (23.6) 230 (22.6)
 65–74 736 (22.4) 1158 (20.2) 154 (27.9) 267 (26.2)
 75 +  1753 (53.4) 3304 (57.7) 202 (36.6) 402 (39.5)
Female sex, N (%) 1855 (56.5) 3362 (58.7) 0.04 270 (48.9) 507 (49.8) 0.75
Polymicrobial event, N (%) 200 (6.1) 370 (6.5) 0.49 79 (14.3) 153 (15.0) 0.71

Holiday season: July to October

SD Standard deviation

Figure 1 A shows the number of E. coli BSI per month fitted with a periodic model. Seasonality was observed for CO events (Fig. 1 A) and the peak-to-low ratio was 1.24 (95% CI 1.17–1.32) for all ages combined (Fig. 1B) with the peak date on August 10. For HO BSI, no seasonality was observed (Fig. 1 A) with a peak-to-low ratio of 1.15 for all ages combined (95% CI 1.00–1.32) (Fig. 1B) and the peak date on September 2. The seasonality of CO events was stronger in younger age categories than in the 75 + category (Fig. 1B). For CO BSI, the monthly mean number of events was higher in the holiday season than in the rest of the year (410.5 [SD 29.6] vs. 357.9 [SD 35.3], p < 0.001) (Table 1). When season was modeled as 4 categories, the monthly mean number of CO events increased from 336.5 in winter (SD 27.7) to 372.0 (SD 38.9) in spring, 402.5 (SD 35.4) in summer, and then declined slightly in autumn to 390.7 events (SD 37.4) (p = 0.008) (Additional file 1: Table S1).

Fig. 1.

Fig. 1

Seasonality of E. coli bloodstream infections (BSI), by place of onset. a Each dot represents the total observed number of E. coli BSI each month. The lines represent the fitted number of E. coli BSI, using a periodic model. b Peak-to-low ratio (ratio of the peak monthly number of events to the lowest monthly number of events on the sinusoidal curve) and its 95% confidence interval in all ages and by age category

Effect of temperature on incidence

Figure 2 A shows that, among CO E. coli BSI, the monthly number of events increased with temperature only above 25 °C; no correlation was observed among HO BSI. The effect of temperature on the monthly number of CO BSI was stronger in younger age groups (Fig. 2B, C). Table 2 shows the multivariable models of the incidence of E. coli BSI events by place of onset. Among CO events, the monthly number of events increased significantly by 1% per 1 °C, or 6.2% (95% CI 1.6–11.1%) for each 5.5 °C increase (p = 0.008); but season (modelled dichotomously) was not significantly associated with BSI incidence. Among HO events, no significant association was found with temperature nor season.

Fig. 2.

Fig. 2

Association between the incidence of E. coli bloodstream infection (BSI) and temperature. a Each dot represents a month. b Each dot represents a month in a specific 5-year age category. c Coefficient and 95% confidence interval of the simple linear model of the number of events by temperature

Table 2.

The effect of season and temperature on the incidence of E. coli bloodstream infection, by place of onset

Variable Community onset Hospital onset
IRR 95% CI P IRR 95% CI P
Holiday season 1.07 0.97, 1.18 0.2 1.03 0.88, 1.19 0.7
Temperature, °C* 1.01 1.00, 1.02 0.008 1.00 0.99, 1.02 0.6
Female sex 1.42 1.33, 1.52  < 0.001 0.98 0.88, 1.08 0.7
Age category, years
 18–44 – – – –
 45–64 2.18 1.94, 2.44  < 0.001 1.93 1.62, 2.32  < 0.001
 65–74 2.97 2.65, 3.32  < 0.001 2.26 1.90, 2.70  < 0.001
 75 + 7.84 7.05, 8.72  < 0.001 3.25 2.75, 3.85  < 0.001
Number of months since January 2018 1.01 1.00, 1.01 0.02 1.01 1.00, 1.02 0.01

*When temperature was modelled dichotomously as ≤ 25 °Cor > 25 °C, results were IRR 1.16 (95% CI 1.05, 1.27) p = 0.002 for CO BSI and 1.03 (95% CI 0.89, 1.19) p = 0.7 for HO BSI

Holiday season: July to October

IRR Incidence rate ratio, CI confidence interval

Antimicrobial resistance

As shown in Table 3, among CO BSI the number of MDR events significantly increased by 1% per 1 °C, or 4.9% (95% CI 0.3–9.7%) for each  5.5 °C increase (p = 0.04). Season (modelled dichotomously) was not significantly associated with the incidence of MDR BSI. Among HO events, there was no significant association between the incidence of MDR BSI and temperature or season. Non-MDR CO events increased only at temperatures above 25 °C, while MDR CO events started to increase at temperatures above 20 °C (Fig. 3).

Table 3.

Multivariable analysis of the effect of season and temperature on the incidence of multidrug-resistant E. coli bloodstream infection, by place of onset

Variable Community onset Hospital onset
IRR 95% CI P IRR 95% CI P
Holiday season 1.04 0.94, 1.14 0.50 1.00 0.84, 1.20  > 0.9
Temperature, °C 1.01 1.00, 1.02 0.04 1.01 0.99, 1.02 0.30
Female sex 1.10 1.03, 1.18 0.01 0.84 0.74, 0.95 0.01
Age category, years
 18–44 – – – –
 45–64 3.03 2.58, 3.56  < 0.001 1.75 1.41, 2.18  < 0.001
 65–74 4.16 3.57, 4.88  < 0.001 2.04 1.65, 2.53  < 0.001
 75 + 11.4 9.90, 13.3  < 0.001 2.62 2.14, 3.23  < 0.001
Number of months since January 2018 1.01 1.00, 1.01 0.03 1.01 1.00, 1.02 0.14

Holiday season: July to October

IRR Incidence rate ratio, CI confidence interval

Fig. 3.

Fig. 3

Community-onset E. coli bloodstream infections by multidrug-resistance (MDR) status and by temperature

Table 4 summarizes the effects of season and temperature on the incidence of BSI caused by E. coli resistant to specific antibiotics. Among CO events, as temperatures rose, there was a significant increase in the incidence of BSI caused by E. coli resistant to amoxicillin-clavulanic acid or ampicillin-sulbactam, third- or fourth-generation cephalosporins, fluoroquinolones, and MDR E. coli (IRR: 1.01, 95% CI 1.00–1.02 for all); the effect of season was not significant. Among HO events, no significant association was found between the incidence of resistant BSI and temperature or season.

Table 4.

Multivariable analysis of the effect of season and temperature on the incidence of bloodstream infection caused by E. coli with specific antibiotic-resistant profiles, by place of onset

Resistance phenotype Variable Community onset Hospital onset
Resistant/total tested IRR 95% CI P Resistant/total tested IRR 95% CI P
Amoxicillin-clavulanic acid or ampicillin-sulbactam 1020/3009 445/963
Holiday season 1.00 0.90, 1.11  > 0.9 1.07 0.87, 1.33 0.5
Temperature, °C 1.01 1.00, 1.02 0.03 1.01 0.99, 1.03 0.4
3rd- or 4th-generation cephalosporins 964/3236 456/1003
Holiday season 0.94 0.85, 1.05 0.30 0.96 0.78, 1.20 0.7
Temperature, °C 1.01 1.00, 1.02 0.01 1.00 0.98, 1.02 0.8
Fluoroquinolones 1116/3266 495/1014
Holiday season 0.97 0.88, 1.08 0.60 1.04 0.84, 1.28 0.7
Temperature, °C 1.01 1.00, 1.02 0.02 1.00 0.98, 1.02 0.8

All models were adjusted for sex, age category and number of months since January 2018

Holiday season: July to October

IRR Incidence rate ratio, CI confidence interval

Discussion

Our nationwide study showed a seasonal and temperature effect on the incidence of CO E. coli BSI and CO antibiotic-resistant E. coli BSI, but not on HO E. coli BSI. The incidence of CO E. coli BSI increased by 6.2% for each 5.5 °C increase. Similar results were previously found [4, 6], however, without distinction by place of onset. We found a peak-to-low ratio of 1.24 for CO events, equal to the ratio previously found for community-acquired E. coli BSI events in a Danish study conducted in 2000–2011 [5]. Various explanations have been suggested for this association. Season affects human behavior, with summertime increases in outdoor activity, travel, sexual activity, and changes in food consumption that increase both exposure to the environment and inter-human exposure [11, 16, 17]. Higher temperature increases the growth of E. coli in vitro [12], its density in the environment [6, 11], and contamination of food and beverages, leading to an increase in E. coli BSI, possibly through an increase in the incidence of colonization [11]. Temperature could also increase the risk of infection by possibly affecting virulence factors of E. coli and host immunity [10, 11].

In our study, the effect of temperature and season varied with age category; it was strongest in 18–44 year olds and smaller in the oldest age group. In contrast, Gradel et al. found that the effect of seasonality on E. coli BSI did not vary by age and also found little difference in the seasonal variation of the primary source of infection (e.g., urinary tract, intra-abdominal) [5]. Gradel’s study was limited by missing data for the primary source of infection in many cases. The differential effect of seasonality by age found in our study may be explained by a difference in the cause of E. coli BSI. Among 18–44 year olds, E. coli BSI is likely to be secondary to urinary tract infection through sexual activity or intra-abdominal infection through travel and outdoor activities, both varying with season [16, 17], while in the oldest age group E. coli BSI may develop from urinary tract infections caused by urinary devices and urinary retention, the use of invasive devices, and institutionalization [18].

We did not find seasonality in HO E. coli BSI, in accordance with previous studies [7, 9]. One study conducted in Belgium 2000–2014, on several pathogens including E. coli, did report an association between temperature and hospital-acquired BSI [8]. The results of that study might differ from ours because the seasonality of BSI differs between pathogens [5] and because in-hospital climate control may differ between countries. The absence of correlation between outdoor temperature and HO E. coli BSI in the climate-controlled Israeli hospitals suggests that temperature control may be an important infection prevention measure in hospitals.

We found that the monthly number of CO MDR E. coli BSI was associated with temperature, with a 4.9% increase in MDR E. coli BSI for each 5.5 °C rise in outdoor temperature. A study conducted in Oxfordshire, England, between 1999 and 2011 of 2240 E. coli BSI reported a non-significant positive trend between the incidence of resistant events and temperature, regardless of place of onset [4]. A large study of 28 European countries from 2000 to 2016 examined the link between outdoor temperature and the percentage of resistance among several pathogens, including E. coli, in various types of infections [19]. The authors found that a higher annual average minimum outdoor temperature was associated with a higher percentage of E. coli infections that were antibiotic resistant, and a higher rate of increase in the percentage of resistance. Several mechanisms could explain the association between resistance and temperature: carriage of extended-spectrum ß-lactamase-producing E. coli is associated with higher temperature [20], and horizontal gene transfer is temperature dependent [21, 22], with higher temperature enhancing cell-to-cell plasmid transfer in E. coli [23]. In the next decades, global warming could further increase the incidence of MDR E. coli BSI.

The strengths of our study were its nationwide scale and the fact that we considered place of BSI onset when studying the effects of seasonality and temperature. Our study had several limitations. First, our data were limited to two years, which diminished the power of our analysis and prevented us from defining more precisely a cut-off for the effect of temperature. Second, CO BSI included both healthcare-associated and true community-acquired events; because the anatomic source of BSI differs between those two types of acquisition, it would be interesting to study seasonality of those events separately. Third, because we had no data on behavioral factors or source of infection, we could not test whether behavioral factors could explain the seasonality. Fourth, Israel has a small range of temperatures and little difference between seasons; our study should be replicated in a country with greater weather variability to see if our findings are confirmed.

Conclusion

We found that a higher temperature was associated with an increase in total and resistant CO E. coli BSI. Global warming could further increase the incidence of E. coli BSI.

Supplementary Information

13756_2022_1184_MOESM1_ESM.pdf (260.1KB, pdf)

Additional file 1: Table S1. Characteristics of E. coli bloodstream infections by place of onset and by season.

Acknowledgements

We thank all hospital staff involved in reporting to the surveillance system and the staff of the National Institute for Antibiotic Resistance and Infection Control that manages the surveillance system.

Abbreviations

BSI

Bloodstream infection

HO

Hospital-onset

CO

Community-onset

MDR

Multidrug resistance

Author contributions

SFF, ET, AN, and YC conceptualized the study. SFF and ET wrote the initial draft of the manuscript. SFF and LW analyzed the data. SFF prepared the visualizations of the data. RS curated the data and coordinated the study. SFF, ET, LW, AN, VS, PS, YC, RS, MJS, and YC interpreted the results and prepared the final manuscript. SFF, ET, and LW verified the underlying data. All authors have seen and approved the final version.

Funding

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Availability of data and materials

The National Institute for Antibiotic Resistance and Infection Control’s bloodstream infection database is a governmental database to which access is restricted by Israeli regulations. Computer code in R and Episheet is available from the authors upon request.

Declarations

Ethics approval and consent to participate

This study was approved by the Tel Aviv Sourasky Medical Center Institutional Review Board (#0307-21-TLV). The requirement for informed consent was waived for this study of de-identified, routinely collected surveillance data.

Consent for publication

Not applicable.

Competing interests

YC has received grants from Pfizer and Shinogi; personal fees from Pfizer, Allecra, Nabriva therapeutics, Roche, Genetech, Qpex biopharma, and Merck Sharpe & Dohme; and is on the Data Safety Monitoring Board or Advisory Board of Pfizer, Merck Sharpe & Dohme, Venatorx pharmaceuticals, and Enlivex therapeutics, outside the submitted work. All other authors declare no competing interests.

Footnotes

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  • 1.Temkin E, Fallach N, Almagor J, Gladstone BP, Tacconelli E, Carmeli Y, Consortium DRIVE-AB. Estimating the number of infections caused by antibiotic-resistant Escherichia coli and Klebsiella pneumoniae in 2014: a modelling study. Lancet Glob Heal. 2018 doi: 10.1016/S2214-109X(18)30278-X. [DOI] [PubMed] [Google Scholar]
  • 2.Feldman SF, Temkin E, Wullfhart L, Nutman A, Schechner V, Shitrit P, Shvartz R, Schwaber MJ, Andremont A, Carmeli Y. A nationwide population-based study of Escherichia coli bloodstream infections: incidence, antimicrobial resistance and mortality. Clin Microbiol Infect. 2022 doi: 10.1016/j.cmi.2021.12.009. [DOI] [PubMed] [Google Scholar]
  • 3.Bonten M, Johnson JR, van den Biggelaar AHJ, Georgalis L, Geurtsen J, de Palacios PI, Gravenstein S, Verstraeten T, Hermans P, Poolman JT. Epidemiology of Escherichia coli bacteremia: a systematic literature review. Clin Infect Dis. 2021 doi: 10.1093/cid/ciaa210. [DOI] [PubMed] [Google Scholar]
  • 4.Schlackow I, Stoesser N, Walker AS, Crook DW, Peto TEA, Wyllie DH, Infections in Oxfordshire Research Database Team Increasing incidence of Escherichia coli bacteraemia is driven by an increase in antibiotic-resistant isolates: electronic database study in Oxfordshire 1999–2011. J Antimicrob Chemother. 2012 doi: 10.1093/jac/dks082. [DOI] [PubMed] [Google Scholar]
  • 5.Gradel KO, Nielsen SL, Pedersen C, Knudsen JD, Østergaard C, Arpi M, Jensen TG, Kolmos HJ, Søgaard M, Lassen AT, Schønheyder HC. Danish collaborative Bacteraemia Network (DACOBAN) and the danish Observational Registry of Infectious Syndromes (DORIS). Seasonal variation of Escherichia coli, Staphylococcus aureus, and Streptococcus pneumoniae bacteremia according to acquisition and patient characteristics: a population-based study. Infect Control Hosp Epidemiol. 2016 doi: 10.1017/ice.2016.89. [DOI] [PubMed] [Google Scholar]
  • 6.Al-Hasan MN, Lahr BD, Eckel-Passow JE, Baddour LM. Seasonal variation in Escherichia coli bloodstream infection: a population-based study. Clin Microbiol Infect. 2009 doi: 10.1111/j.1469-0691.2009.02877.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Alcorn K, Gerrard J, Macbeth D, Steele M. Seasonal variation in health care-associated bloodstream infection: increase in the incidence of gram-negative bacteremia in nonhospitalized patients during summer. Am J Infect Control. 2013 doi: 10.1016/j.ajic.2013.05.019. [DOI] [PubMed] [Google Scholar]
  • 8.Blot K, Hammami N, Blot S, Vogelaers D, Lambert M-L. Seasonal variation of hospital-acquired bloodstream infections: a national cohort study. Infect Control Hosp Epidemiol. 2022 doi: 10.1017/ice.2021.85. [DOI] [PubMed] [Google Scholar]
  • 9.Deeny SR, van Kleef E, Bou-Antoun S, Hope RJ, Robotham JV. Seasonal changes in the incidence of Escherichia coli bloodstream infection: variation with region and place of onset. Clin Microbiol Infect. 2015 doi: 10.1016/j.cmi.2015.06.023. [DOI] [PubMed] [Google Scholar]
  • 10.Chazan B, Colodner R, Edelstein H, Raz R. Seasonal variation in Escherichia coli bloodstream infections in northern Israel. Clin Microbiol Infect. 2011 doi: 10.1111/j.1469-0691.2010.03327.x. [DOI] [PubMed] [Google Scholar]
  • 11.Freeman JT, Anderson DJ, Sexton DJ. Seasonal peaks in Escherichia coli infections: possible explanations and implications. Clin Microbiol Infect. 2009 doi: 10.1111/j.1469-0691.2009.02866.x. [DOI] [PubMed] [Google Scholar]
  • 12.Bronikowski AM, Bennett AF, Lenski RE. Evolutionary adaptation to temperature. VIII. Effects of temperature on growth rate in natural isolates of Escherichia coli and Salmonella enterica from different thermal environments. Evolution. 2001 doi: 10.1554/0014-3820(2001)055[0033:EATTVE]2.0.CO;2. [DOI] [PubMed] [Google Scholar]
  • 13.Israeli Ministry of Transportation. Israel Government Portal. Meteorological Service databases. 2021. https://ims.data.gov.il/.
  • 14.Magiorakos A-P, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, Harbarth S, Hindler JF, Kahlmeter G, Olsson-Liljequist B, Paterson DL, Rice LB, Stelling J, Struelens MJ, Vatopoulos A, Weber JT, Monnet DL. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012 doi: 10.1111/j.1469-0691.2011.03570.x. [DOI] [PubMed] [Google Scholar]
  • 15.Brookhart MA, Rothman KJ. Simple estimators of the intensity of seasonal occurrence. BMC Med Res Methodol. 2008 doi: 10.1186/1471-2288-8-67. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Cornelisse VJ, Chow EPF, Chen MY, Bradshaw CS, Fairley CK. Summer heat: a cross-sectional analysis of seasonal differences in sexual behaviour and sexually transmissible diseases in Melbourne, Australia. Sex Transm Infect. 2016 doi: 10.1136/sextrans-2015-052225. [DOI] [PubMed] [Google Scholar]
  • 17.Wellings K, Macdowall W, Catchpole M, Goodrich J. Seasonal variations in sexual activity and their implications for sexual health promotion. J R Soc Med. 1999 doi: 10.1177/014107689909200204. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Leibovici-Weissman Y, Tau N, Yahav D. Bloodstream infections in the elderly: what is the real goal? Aging Clin Exp Res. 2021 doi: 10.1007/s40520-019-01337-w. [DOI] [PubMed] [Google Scholar]
  • 19.McGough SF, MacFadden DR, Hattab MW, Mølbak K, Santillana M. Rates of increase of antibiotic resistance and ambient temperature in Europe: a cross-national analysis of 28 countries between 2000 and 2016. Euro Surveill. 2020 doi: 10.2807/1560-7917.ES.2020.25.45.1900414. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Kaier K, Frank U, Conrad A, Meyer E. Seasonal and ascending trends in the incidence of carriage of extended-spectrum ß-lactamase-producing Escherichia coli and Klebsiella species in 2 german hospitals. Infect Control Hosp Epidemiol. 2010 doi: 10.1086/656748. [DOI] [PubMed] [Google Scholar]
  • 21.Lorenz MG, Wackernagel W. Bacterial gene transfer by natural genetic transformation in the environment. Microbiol Rev. 1994 doi: 10.1128/mr.58.3.563-602.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Walsh TR, Weeks J, Livermore DM, Toleman MA. Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence study. Lancet Infect Dis. 2011 doi: 10.1016/S1473-3099(11)70059-7. [DOI] [PubMed] [Google Scholar]
  • 23.Hashimoto M, Hasegawa H, Maeda S. High temperatures promote cell-to-cell plasmid transformation in Escherichia coli. Biochem Biophys Res Commun. 2019 doi: 10.1016/j.bbrc.2019.05.134. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

13756_2022_1184_MOESM1_ESM.pdf (260.1KB, pdf)

Additional file 1: Table S1. Characteristics of E. coli bloodstream infections by place of onset and by season.

Data Availability Statement

The National Institute for Antibiotic Resistance and Infection Control’s bloodstream infection database is a governmental database to which access is restricted by Israeli regulations. Computer code in R and Episheet is available from the authors upon request.


Articles from Antimicrobial Resistance and Infection Control are provided here courtesy of BMC

RESOURCES